Condition: Schizophrenia · Cognition · Sponsor: Douglas Mental Health University Institute
The goal of this clinical trial is to effectively implement virtually-delivered interventions in mental health institutions nationwide to improve the cognitive health of individuals living with schizophrenia. The main objectives are: * To determine the clinical effectiveness of two virtual cognitive health interventions (i.e., Action-Based Cognitive Remediation or MetaCognitive Training). * To evaluate our implementation strategy involving the virtual delivery of cognitive health interventions combined with a digital learning platform to train mental health practitioners. Participants will be assessed for the severity of symptoms, cognitive performance, and overall functioning before and after receiving the intervention. Qualitative interviews will also be conducted with participants and therapists to evaluate the implementation strategies.
This description comes directly from the study's public registry record.
Karyne Anselmo · (514) 761-6131 · karyne.anselmo@douglas.mcgill.ca
Always discuss trial participation with your own doctor first.
| Faculty of Medicine, University of British Columbia | Vancouver, British Columbia, Canada | Not Yet Recruiting |
| Kingston Health Sciences Centre, Queen's University | Kingston, Ontario, Canada | Recruiting |
| Institute of Mental Health Research, University of Ottawa | Ottawa, Ontario, Canada | Recruiting |
| Ontario Shoares Centre for Mental Health Sciences, University of Toronto | Toronto, Ontario, Canada | Recruiting |
| Douglas Mental Health University Institute | Montreal, Quebec, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05661448